首页 / 院系成果 / 成果详情页

LATITUDE, a phase 3 double-blind, randomized trial of androgen deprivation therapy (ADT) with abiraterone acetate (AA) plus prednisone (P) or placebos (PBOs) in patients (pts) with newly diagnosed high-risk metastatic hormone-naive prostate cancer (mHNPC)  会议论文  

  • 编号:
    a6ecac86-4d2a-44f0-9223-b89ffc603906
  • 作者:
    Feyerabend, S.; Tran, N.; Fein, L.; Matsubara, N.; Rodriguez Antolin, A.; Alekseev, B.; Ozguroglu, M.; Ye, D.; Protheroe, A.; De Porre, P.; Kheoh, T.; Park, Y. C.; Todd, M.; Chi, K.; Fizazi, K.
  • 作者单位:
    [Feyerabend, S.] Studienpraxis Urol, Teutlingen, Germany; [Tran, N.] Janssen Res & Dev, Los Angeles, CA USA; [Fein, L.] Inst Oncol Rosario, Rosario, Santa Fe, Argentina; [Matsubara, N.] Natl Canc Ctr Hosp East, Chiba, Japan; [Rodriguez Antolin, A.] 12 Octubre Univ Hosp, Madrid, Spain; [Alekseev, B.] PA Herzen Moscow Canc Res Inst, Moscow, Russia; [Ozguroglu, M.] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey; [Ye, D.] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai, Peoples R China; [Protheroe, A.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [De Porre, P.] Janssen Res & Dev, Beerse, Belgium; [Kheoh, T.] Janssen Res & Dev, San Diego, CA USA; [Park, Y. C.; Todd, M.] Janssen Res & Dev, Raritan, NJ USA; [Chi, K.] BC Canc Agcy, Vancouver, BC, Canada; [Fizazi, K.] Univ Paris Sud, Gustave Roussy, Villejuif, France
  • 会议名称:
    ONCOLOGY RESEARCH AND TREATMENT
  • 会议时间:
  • 出版信息:
    2017 年 40 卷 (113 - 113)
浏览次数:6 下载次数:0
浏览次数:6
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部